Is HbA1c a valid surrogate for mortality in type 2 diabetes? Evidence from a meta-analysis of randomized trials

AIMS: Hemoglobin A1c (HbA1c) has been repeatedly questioned as a valid surrogate marker, especially for patient-relevant outcomes. The aim of this study was to validate the HbA1c value as a surrogate for all-cause mortality in people with type 2 diabetes. METHODS: The effect estimates for HbA1c lowe...

Descripción completa

Detalles Bibliográficos
Autores principales: Baechle, Christina, Scherler, Wiebke, Lang, Alexander, Filla, Tim, Kuss, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402721/
https://www.ncbi.nlm.nih.gov/pubmed/35534726
http://dx.doi.org/10.1007/s00592-022-01887-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402721/
https://www.ncbi.nlm.nih.gov/pubmed/35534726
http://dx.doi.org/10.1007/s00592-022-01887-y

Ejemplares similares